Figure 1: Mean ± Sd Norethindrone Plasma Concentrations Following Norethindrone Administration (Norethindrone Fig1)
Lyleq Tablet
Product Images NDC 50102-300
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lyleq (NDC 50102-300). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Afaxys Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Blister Pack (Norethindrone Fig2)
Package Label-principal Display Panel (0.35 mg 1 Blister Pack 28 Tablets)
This is a medication called "Norethindrone Tablets USP" - oral contraceptives that prevent pregnancy. However, it does NOT offer protection against HIV and other sexually transmitted diseases. The package consists of one blister pack with 28 tablets. Additional information is not available due to the poor quality of the text recognized by .*
Package Label-principal Display Panel (0.35 mg 3 Blister Carton 28 Tablets)
Product description:
This is a product named "Lyleq" (Norethindrone Tablets USP) which contains 0.35mg and is intended to prevent pregnancy. It does not protect against infections or sexually transmitted diseases. The packaging should not be printed in the over-printing zone and there is also a varnish zone. Some other text mentions "Bt Pk, Tt Ren" and "R3S &2 DR B E" which are unclear in their meaning. The rest of the text seems to be unreadable due to poor quality.*
Chemical Structure (Norethindrone Str)
Norethindrone is an oral contraceptive belonging to the therapeutic class.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
